A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT06035393 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

82

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's R\&D strategy adjusted.

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: HRG2005 inhalation
DRUG: Placebo to match HRG2005 inhalation
DRUG: Placebo to match Indacaterol Maleate and Glycopyrronium Bromide Powder for inhalation
DRUG: Indacaterol Maleate and Glycopyrronium Bromide Powder for inhalation

Sponsor

Jiangsu HengRui Medicine Co., Ltd.